Structure, substrate recognition and reactivity of Leishmania major mevalonate kinase

Sgraja, Tanja; Smith, Terry K.; Hunter, William N.
January 2007
BMC Structural Biology;2007, Vol. 7, p1
Academic Journal
Background: Isoprenoid precursor synthesis via the mevalonate route in humans and pathogenic trypanosomatids is an important metabolic pathway. There is however, only limited information available on the structure and reactivity of the component enzymes in trypanosomatids. Since isoprenoid biosynthesis is essential for trypanosomatid viability and may provide new targets for therapeutic intervention it is important to characterize the pathway components. Results: Putative mevalonate kinase encoding genes from Leishmania major (LmMK) and Trypanosoma brucei (TbMK) have been cloned, over-expressed in and proteins isolated from procyclic-form T. brucei. A highly sensitive radioactive assay was developed and shows ATP-dependent phosphorylation of mevalonate. Apo and (R)-mevalonate bound crystal structures of LmMK, from a bacterial expression system, have been determined to high resolution providing, for the first time, information concerning binding of mevalonate to an MK. The mevalonate binds in a deep cavity lined by highly conserved residues. His25 is key for binding and for discrimination of (R)- over (S)-mevalonate, with the main chain amide interacting with the C3 hydroxyl group of (R)-mevalonate, and the side chain contributing, together with Val202 and Thr283, to the construction of a hydrophobic binding site for the C3 methyl substituent. The C5 hydroxyl, where phosphorylation occurs, points towards catalytic residues, Lys18 and Asp155. The activity of LmMK was significantly reduced compared to MK from other species and we were unable to obtain ATP-binding data. Comparisons with the rat MK:ATP complex were used to investigate how this substrate might bind. In LmMK, helix a2 and the preceding polypeptide adopt a conformation, not seen in related kinase structures, impeding access to the nucleotide triphosphate binding site suggesting that a conformational rearrangement is required to allow ATP binding. Conclusion: Our new structural information, consistent with data on homologous enzymes allows a detailed description of how mevalonate is recognized and positioned for catalysis in MK. The mevalonate-binding site is highly conserved yet the ATP-binding site is structurally distinct in LmMK. We are unable to provide a definitive explanation for the low activity of recombinant protein isolated from a bacterial expression system compared to material isolated from procyclic-form Trypanosoma brucei.


Related Articles

  • ACTIVATION OF A PROTEIN KINASE DURING ACANTHOLYSIS. Decker, Richard H. // Journal of Investigative Dermatology;Aug71, Vol. 57 Issue 2, p125 

    A protein kinase was demonstrated in epidermis and esophageal epithelium. In the presence of adenosine triphosphate (ATP) the enzyme phosphorylated phosvitin and casein but had relatively little activity toward epidermal protons. Slices of epidermis which were treated with cantharidin prior to...

  • Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. Ponticos, Markella; Qi Long Lu; Morgan, Jennifer E.; Hardie, D. Grahame; Partidge, Terence A.; Carling, David // EMBO Journal;3/15/98, Vol. 17 Issue 6, p1688 

    The AMP-activated protein kinase (AMPK) is activated by a fall in the ATP:AMP ratio within the cell in response to metabolic stresses. Once activated, it phosphorylates and inhibits key enzymes in energy­consuming biosynthetic pathways, thereby conserving cellular ATP. The creatine...

  • Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors. Mucs, Daniel; Bryce, Richard A.; Bonnet, Pascal // Journal of Computer-Aided Molecular Design;Jun2011, Vol. 25 Issue 6, p569 

    The identification of new, potent and selective inhibitors of important protein kinase targets is a major goal of drug discovery. Here we analyze the crystal structures of 55 protein kinase complexes with Type II inhibitors and find they adopt a conserved twisted V-shape, with an angle of 121...

  • CYCLIC 3',5'-ADENOSINE MONOPHOSPHATE-STIMULATED PROTEIN KINASE FROM HUMAN SKIN. Kumar, Raj; Tao, Mariano; Solomon, Lawrence M. // Journal of Investigative Dermatology;Nov71, Vol. 57 Issue 5, p312 

    A cyclic AMP-stimulated protein kinase which catalyzes the phosphorylation of histone by ATP, has been partially purified from human skin. Protamine, casein and albumin also served as protein acceptors for the enzyme but were much less efficient than histone. The activity of the enzyme was...

  • Non-ATP Competitive Protein Kinase Inhibitors. Garuti, L.; Roberti, M.; Bottegoni, G. // Current Medicinal Chemistry;Sep2010, Vol. 17 Issue 25, p2804 

    Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors are ATP-competitive and are called type I inhibitors. The ATP-binding pocket is highly conserved among members of the kinase family and it is difficult to find selective agents. Moreover, the...

  • Strategies for the Design of Selective Protein Kinase Inhibitors. Sawa, Masaaki // Mini Reviews in Medicinal Chemistry;Oct2008, Vol. 8 Issue 12, p1291 

    Most kinase inhibitors reported so far are designed to bind to a highly conserved ATP binding pocket in a competitive manner. In this case, inhibitors targeting the ATP pocket may crossreact with different kinases, as well as with other proteins that bind ATP, and this may cause undesirable side...

  • Subcellular localization of protein kinase CK2: A key to its function? Faust, Michael; Montenarh, Mathias // Cell & Tissue Research;Sep2000, Vol. 301 Issue 3, p329 

    More than 46 years ago, Burnett and Kennedy first described protein kinase CK2 (formerly known as casein kinase 2) in liver extracts. Since then, protein kinase CK2 has been investigated in many organisms from yeast to man. It is now well established that protein kinase CK2 is a pleiotropic and...

  • Protein Kinase.  // Encyclopedic Reference of Cancer;2001, p728 

    A definition of the term "protein kinase," is presented. It refers to enzymes that move phosphate from adenosine triphosphate to serine, threonine or tyrosine residues in another protein.

  • ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system. Polier, Sigrun; Samant, Rahul S; Clarke, Paul A; Workman, Paul; Prodromou, Chrisostomos; Pearl, Laurence H // Nature Chemical Biology;Jun2013, Vol. 9 Issue 6, p406 

    A correction to the article "ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system" that was published in the earlier issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics